Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)
The goal of this clinical trial is to learn whether IBD patients have better disease outcomes and feel more empowered to manage their condition if they have access to text messaging with their clinical team and if their symptoms are more regularly monitored through text-based surveys. Researchers will compare participants who have access to text-based monitoring, communication and education to participants who have access to text-based education alone. Researchers will also examine if different social and other non-medical factors impact IBD symptoms and quality of life. All participants will: * complete 5 brief on-line surveys over 12 months about their IBD and social risk factors, * receive IBD education content by text message up to 2 times a week. Some participants will also: * receive additional surveys by text to monitor their IBD progression, * have the opportunity to directly text message their IBD medical team.
• 13+ years old with IBD (Crohn's disease, ulcerative colitis, indeterminant colitis).
• Followed at a participating site with an office visit (in-person or virtual) within the preceding 12 months.
• Have access to a mobile phone and willing and able to receive and respond to text messages.
• Willing to answer questions on electronic surveys.
• Have the ability to read text messages and answer surveys in English or Spanish.